US 8,557,959 B2 · Allele and isotope-specific intervention on MHC class II molecules associated with autoimmune diseases by means of peptides

Abstract

The present invention relates to a peptide for the treatment or prophylaxis of an autoimmune disease, a nucleic acid molecule coding for said peptide, a pharmaceutical composition comprising the peptide and/or the nucleic acid molecule, and to a method for the treatment and/or prophylaxis of an autoimmune disease.

Claims1

Dependent claims

A peptide of nine amino acid residues in length which has an amino acid sequence selected from the group consisting of SEQ ID NO:1 to SEQ ID NO:15.

Dependencies are inferred from the claim text.

Facts

Application

12/746,098Filed 3 Dec 2008

Priority

DE 10 2007 059 9243 Dec 2007

Published

US 2011/0053840 A13 Mar 2011

Granted

15 Oct 2013

Term ends

Not estimatedThe source records don’t support an estimate.

Classification6 codes

C07K 7/06
Linear peptides containing only normal peptide links: having 5 to 11 amino acids
A61K 38/08
Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof: peptides having 5 to 11 amino acids
A61K 39/0008
Vertebrate antigens: antigens related to auto-immune diseases; Preparations to induce self-tolerance
C07K 7/08
Linear peptides containing only normal peptide links: having 12 to 20 amino acids

Allele and isotope-specific intervention on MHC class II molecules associated with autoimmune diseases by means of peptides

Life of this patent

Abstract

Claims1

Allele and isotope-specific intervention on MHC class II molecules associated with autoimmune diseases by means of peptides

Life of this patent

Abstract

Claims1